首页 | 本学科首页   官方微博 | 高级检索  
文章检索
  按 检索   检索词:      
出版年份:   被引次数:   他引次数: 提示:输入*表示无穷大
  收费全文   1080245篇
  免费   73597篇
  国内免费   1379篇
耳鼻咽喉   15161篇
儿科学   35133篇
妇产科学   28835篇
基础医学   154132篇
口腔科学   29689篇
临床医学   95396篇
内科学   204888篇
皮肤病学   24562篇
神经病学   81868篇
特种医学   43135篇
外国民族医学   201篇
外科学   164277篇
综合类   21834篇
现状与发展   1篇
一般理论   264篇
预防医学   74981篇
眼科学   24757篇
药学   86662篇
  7篇
中国医学   2836篇
肿瘤学   66602篇
  2019年   7899篇
  2018年   11489篇
  2017年   9067篇
  2016年   10299篇
  2015年   11473篇
  2014年   15572篇
  2013年   22558篇
  2012年   31085篇
  2011年   32850篇
  2010年   19315篇
  2009年   18034篇
  2008年   30367篇
  2007年   32429篇
  2006年   33061篇
  2005年   31379篇
  2004年   30027篇
  2003年   28820篇
  2002年   27749篇
  2001年   60121篇
  2000年   61577篇
  1999年   51037篇
  1998年   12504篇
  1997年   11040篇
  1996年   11049篇
  1995年   10365篇
  1994年   9374篇
  1993年   8886篇
  1992年   37828篇
  1991年   36312篇
  1990年   35782篇
  1989年   34332篇
  1988年   30902篇
  1987年   30023篇
  1986年   28248篇
  1985年   26479篇
  1984年   19217篇
  1983年   16145篇
  1982年   8839篇
  1979年   17056篇
  1978年   11430篇
  1977年   10247篇
  1976年   8861篇
  1975年   10108篇
  1974年   11668篇
  1973年   11298篇
  1972年   10761篇
  1971年   10113篇
  1970年   9271篇
  1969年   8957篇
  1968年   7931篇
排序方式: 共有10000条查询结果,搜索用时 17 毫秒
1.
2.
Quality of Life Research - The COVID-19 pandemic might add to the stressors experienced by people living with rheumatic diseases. This study aimed to examine rheumatic patients’ functional...  相似文献   
3.
Molnár  B.  Aroca  S.  Dobos  A.  Orbán  K.  Szabó  J.  Windisch  P.  Stähli  A.  Sculean  A. 《Clinical oral investigations》2022,26(12):7135-7142
Clinical Oral Investigations - To evaluate t he long-term outcomes following treatment of RT 1 multiple adjacent gingival recessions (MAGR) using the modified coronally advanced tunnel (MCAT) with...  相似文献   
4.
5.
6.
7.
IntroductionHip displacement is common in cerebral palsy (CP) and is related to the severity of neurological and functional impairment. It is a silent, but progressive disease, and can result in significant morbidity and decreased quality of life, if left untreated. The pathophysiology of hip displacement in CP is a combination of hip flexor-adductor muscle spasticity, abductor muscle weakness, and delayed weight-bearing, resulting in proximal femoral deformities and progressive acetabular dysplasia. Due to a lack of symptoms in the early stages of hip displacement, the diagnosis is easily missed. Awareness of this condition and regular surveillance by clinical examination and serial radiographs of the hips are the key to early diagnosis and treatment.Hip surveillance programmesSeveral population-based studies from around the world have demonstrated that universal hip surveillance in children with CP allows early detection of hip displacement and appropriate early intervention, with a resultant decrease in painful dislocations. Global hip surveillance models are based upon the patients’ age, functional level determined by the Gross Motor Function Classification system (GMFCS), gait classification, standardized clinical exam, and radiographic indices such as the migration percentage (MP), as critical indicators of progressive hip displacement.ConclusionDespite 25 years of evidence showing the efficacy of established hip surveillance programmes, there is poor awareness among healthcare professionals in India about the importance of regular hip surveillance in children with CP. There is a need for professional organizations to develop evidence-based guidelines for hip surveillance which are relevant to the Indian context.  相似文献   
8.
9.
Inflammatory bowel disease (IBD) is a chronic disease that requires chronic treatment throughout the evolution of the disease, with a complex physiopathology that entails great challenges for the development of new and specific treatments for ulcerative colitis and Crohn´s disease. The anti-tumor necrosis factor alpha therapy has impacted the clinical course of IBD in those patients who do not respond to conventional treatment, so there is a need to develop new therapies and markers of treatment response. Various pathways involved in the development of the disease are known and the new therapies have focused on blocking the inflammatory process at the gastrointestinal level by oral, intravenous, subcutaneous, and topical route. All these new therapies can lead to more personalized treatments with higher success rates and fewer relapses. These treatments have not only focused on clinical remission, but also on achieving macroscopic changes at the endoscopic level and microscopic changes by achieving mucosal healing. These treatments are mainly based on modifying signaling pathways, by blocking receptors or ligands, reducing cell migration and maintaining the integrity of the epithelial barrier. Therefore, this review presents the efficacy and safety of the new treatments that are currently under study and the advances that have been made in this area in recent years.  相似文献   
10.
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号